CLDF Title
Home | Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
 
Back  
 
Reuters Health Information (2006-04-12): Glial cell activity involved in hepatic encephalopathy

Clinical

Glial cell activity involved in hepatic encephalopathy

Last Updated: 2006-04-12 13:03:04 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Patients with hepatic encephalopathy show increased expression of peripheral benzodiazepine binding sites (PBBS) by glial cells, according to a report by Australian researchers in the April issue of Gut.

Previous research has implicated PBBS in the pathogenesis of hepatic encephalopathy, the authors point out. They hypothesized that PBBS-expressing glial cells participate in the general inflammatory response seen in hepatic encephalopathy.

Dr. R. B. Banati from the University of Sydney, Lidcombe and colleagues investigated whether there is a change in PBBS expression in the brains of patients with minimal hepatic encephalopathy and related regional patterns of increased expression to the underlying severity of liver disease and to psychometric test results.

Analysis of PET scans of five patients with hepatic encephalopathy revealed increased PBBS expression bilaterally in the pallidum, in the right putamen, and in the right dorsolateral prefrontal region, the authors report.

Increased PBBS expression was related to the severity of cognitive decline, but it appeared to be unrelated to the etiology of the disease or other clinical characteristics.

The authors suggest that "the apparent link between up-regulation of [PBBS] and cognitive decline, the key symptom for minimal hepatic encephalopathy, supports the hypothesis that PBBS in the brain could indeed participate in the pathogenic mechanism of hepatic encephalopathy."

"This further implies," they conclude, "that glial cell dysfunction is pivotal in this process, as the binding sites... are exclusively non-neuronal and, given an intact blood-brain barrier, have been shown to be expressed only by activated or reactive glia."

Gut 2006;55:547-553.

 
 
 
 
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
CME Dinner Meeting
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.